Our consultant directory offers information on who our consultants are, their specialities and where they are based.
If you have an enquiry relating to your appointment or your treatment, you should contact the relevant department instead of your individual consultant to ensure that our clinical support team can provide you with the right support to your enquiry in a timely manner.
Our consultant directory offers information on who our consultants are, their specialities and where they are based.
If you have an enquiry relating to your appointment or your treatment, you should contact the relevant department instead of your individual consultant to ensure that our clinical support team can provide you with the right support to your enquiry in a timely manner.
Dr. Adeel Iqbal is a London-based NHS Consultant Physician with specialist expertise in Acute Medicine and Geriatrics. A graduate of Imperial College London, he was awarded the prestigious Rector’s Outstanding Achievement Gold Medal, alongside multiple academic prizes for top performance in undergraduate examinations, including the Abraham’s Award for Medical Pathology. He holds a First-Class Honours degree in Cardiovascular Sciences from the National Heart and Lung Institute and was the recipient of the Patrick Trevor-Roper Scholarship.
His academic contributions include published research on stem cell technology, cardiovascular disease, and the long-term sequelae of COVID-19. In recognition of his expertise, he has served as an independent Consultant to Pfizer and as an academic speaker for Bristol-Myers Squibb. His excellence in communication has been acknowledged with the Lord Eric Avebury Prize for Public Speaking and Teaching.
A committed educator, Dr. Iqbal has lectured internationally to undergraduate and postgraduate audiences, and as founder of the International Education Fund at Imperial College, he was honoured with the BMA Humanitarian Fund Award. Beyond clinical and academic medicine, he is a Trustee of Developing World Healthcare, a registered UK charity delivering a state-of-the-art, internationally accredited teaching hospital in Kashmir.
Dr. Adeel Iqbal’s research portfolio reflects a strong commitment to advancing understanding of cardiopulmonary disease, regenerative medicine, and the long-term effects of emerging health challenges. He has co-authored influential work on cardiopulmonary sequelae of long-term COVID-19, published in Frontiers in Medicine (2022), which explores current perspectives and challenges in post-viral morbidity. Earlier, his research at Imperial College London focused on human embryonic stem cell-derived cardiomyocytes and endothelial cells, investigating how immunosuppressive agents modulate their growth, function, and survival, with findings published in Stem Cells and Development (2014). Dr. Iqbal has also presented internationally on the calcineurin–NFAT signalling pathway in cardiac cell proliferation, contributing to symposia in London and Hungary. His interests lie at the intersection of cardiovascular pathophysiology, cellular therapy, and translational medicine, with a vision to bridge laboratory science and clinical practice in tackling complex conditions such as heart failure, pulmonary hypertension, and long-term complications of COVID-19.
Oliveira, R.K.F., Nyasulu, P.S., Iqbal, A., Hamdan Gul, M., Ferreira, E.V.M., Leclair, J.W., Htun, Z.M., Howard, L.S., Mocumbi, A.O., Bryant, A.J., Tamuzi, J.L., Avdeev, S., Petrosillo, N., Hassan, A., Butrous, G. and de Jesus Perez, V., 2022. Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges. Frontiers in Medicine, 9, p.1041236.
Földes, G., Mioulane, M., Kodagoda, T., Lendvai, Z., Iqbal, A., Ali, N.N., Schneider, M.D. and Harding, S.E., 2014. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. Stem Cells and Development, 23(5), pp.467–476.
Földes, G., Mioulane, M., Iqbal, A., Schneider, M.D., Ali, N.N. and Harding, S.E., 2013. Growth and proliferative activity of human embryonic stem cell-derived cardiomyocytes is modulated in a calcineurin–NFAT-dependent manner. International Conference Presentation, NHLI, Imperial College London & Hungary.
Dr. Adeel Iqbal’s leadership spans clinical care, education, governance, and international collaboration. He is an active member of the acute and frailty services, overseeing diagnosis, treatment, and patient-centred management in inpatient and outpatient settings. He develops protocols, directs safety initiatives, and supervises complex cases hospital-wide. As a certified QI Coach, he drives audits and quality improvement, including establishing an Enhanced Care Unit. A dedicated educator, he has delivered over 300 lectures globally, mentors consultants and trainees, and leads MRCP programmes. Internationally, he contributes to pulmonary vascular research, conferences, and global education, underpinned by excellence in patient advocacy.